We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Chondroitin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
7 of 11 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
4 of 8 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Chondroitin and DHEA have evidence — compare verdict strength side-by-side.
800-1200mg
With meals, Once daily or split into 2-3 doses
Chondroitin sulfate from bovine or marine sources
25-50mg for women; 50-100mg for men (start low)
Morning (mimics natural rhythm)
Micronized DHEA capsules
8-12 weeks
12+ weeks
6-24 months
4-8 weeks
8-12 weeks
Meta-analysis: chondroitin for osteoarthritis of the knee or hip
Annals of internal medicine (2007) · Meta analysis · n=3846
Large-scale, methodologically sound trials indicate that the symptomatic benefit of chondroitin is minimal or nonexistent.
The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review
Nutrients (2025) · Systematic review · n=146
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Systematic review and network meta-analysis on the efficacy and safety of parmacotherapy for hand osteoarthritis
PloS one (2024) · Meta analysis · n=3965
GCSB-5, a specific herbal complex that mainly regulate pain in hand osteoarthritis, showed the greatest reduction in pain [WMD = -13.00, 95% CI (-26.69, 0.69)].
Dehydroepiandrosterone for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials
Journal of neuroscience research (2020) · Meta analysis · n=742
No hormonal changes that indicated any risk to the participants' health were seen.
Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review
Annals of internal medicine (2024) · Systematic review
Vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may improve some GSM symptoms in the short term.
TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis
Reproductive biology and endocrinology : RB&E (2023) · Meta analysis · n=2323
Compared with the control group, CoQ10 (OR 2.22, 95% CI: 1.05 to 4.71) and DHEA (OR 1.92, 95% CI: 1.16 to 3.16) had obvious advantages in improving the clinical pregnancy rate.
Large meta-analyses show minimal to nonexistent benefits. Effects appear modest at best, with significant study heterogeneity. Combination with glucosamine may be more effective than chondroitin alone.
Based on meta-analysis showing OR 1.92 for clinical pregnancy rate in poor ovarian response patients. Effect specific to fertility treatment context with medical supervision. Limited long-term safety data.
AI-estimated from published studies. Interpret as directional guidance.
Chondroitin has a higher evidence score (9/10 vs 9/10) and wins in 2 of 3 categories.
No known interactions between Chondroitin and DHEA have been documented in our database. However, always consult a healthcare provider before combining supplements.